Suppr超能文献

造血系统恶性肿瘤亚克隆发生和依赖性的体内模型。

In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.

机构信息

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

出版信息

Cancer Cell. 2024 Nov 11;42(11):1955-1969.e7. doi: 10.1016/j.ccell.2024.10.009.

Abstract

Cancer evolution is a multifaceted process leading to dysregulation of cellular expansion and differentiation through somatic mutations and epigenetic dysfunction. Clonal expansion and evolution is driven by cell-intrinsic and -extrinsic selective pressures, which can be captured with increasing resolution by single-cell and bulk DNA sequencing. Despite the extensive genomic alterations revealed in profiling studies, there remain limited experimental systems to model and perturb evolutionary processes. Here, we integrate multi-recombinase tools for reversible, sequential mutagenesis from premalignancy to leukemia. We demonstrate that inducible Flt3 mutations differentially cooperate with Dnmt3a, Idh2, and Npm1 mutant alleles, and that changing the order of mutations influences cellular and transcriptional landscapes. We next use a generalizable, reversible approach to demonstrate that mutation reversion results in rapid leukemic regression with distinct differentiation patterns depending upon co-occurring mutations. These studies provide a path to experimentally model sequential mutagenesis, investigate mechanisms of transformation and probe oncogenic dependency in disease evolution.

摘要

癌症进化是一个多方面的过程,通过体细胞突变和表观遗传功能障碍导致细胞扩张和分化失调。克隆扩增和进化是由细胞内在和外在的选择压力驱动的,可以通过单细胞和批量 DNA 测序以越来越高的分辨率来捕获。尽管在分析研究中揭示了广泛的基因组改变,但仍然缺乏用于模拟和干扰进化过程的有限实验系统。在这里,我们整合了多种重组酶工具,用于从癌前病变到白血病的可逆、连续诱变。我们证明,诱导型 Flt3 突变与 Dnmt3a、Idh2 和 Npm1 突变等位基因不同程度地合作,并且突变顺序的改变会影响细胞和转录景观。我们接下来使用一种可推广的、可逆的方法来证明,突变逆转会导致急性白血病迅速消退,并根据共同发生的突变产生不同的分化模式。这些研究为实验模拟连续诱变、研究转化机制以及在疾病进化中探测致癌依赖性提供了一条途径。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验